Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 24, Pages 7551-7556
Publisher
Proceedings of the National Academy of Sciences
Online
2015-06-02
DOI
10.1073/pnas.1506357112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Manipulating immune cells for adoptive immunotherapy of cancer
- (2014) Phillip K Darcy et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting CD137 enhances the efficacy of cetuximab
- (2014) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model
- (2013) A. Morales-Kastresana et al. CLINICAL CANCER RESEARCH
- The contextual role of TNFR family members in CD8+T-cell control of viral infections
- (2013) Michael E. Wortzman et al. IMMUNOLOGICAL REVIEWS
- Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
- (2013) Michael A. Curran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential Localization of T-bet and Eomes in CD8 T Cell Memory Populations
- (2013) L. M. McLane et al. JOURNAL OF IMMUNOLOGY
- T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells
- (2013) Gang Li et al. PLoS One
- Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
- (2013) Jessica Ann Chacon et al. PLoS One
- Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
- (2013) Aizea Morales-Kastresana et al. Journal for ImmunoTherapy of Cancer
- Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8+ memory T cells in the bone marrow
- (2012) Gloria H. Y. Lin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- (2012) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
- (2012) José I Quetglas et al. MOLECULAR THERAPY
- The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
- (2012) Asís Palazón et al. Cancer Discovery
- Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
- (2011) A. Palazon et al. CANCER RESEARCH
- CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation
- (2011) H. Z. Qui et al. JOURNAL OF IMMUNOLOGY
- Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function
- (2011) Jessica Ann Hernandez-Chacon et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- (2010) H. E. Kohrt et al. BLOOD
- Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice
- (2010) Gloria H. Y. Lin et al. PLoS One
- CD137 Promotes Proliferation and Survival of Human B Cells
- (2009) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice
- (2008) Béatrice Breart et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells
- (2008) Seung-Woo Lee et al. NATURE IMMUNOLOGY
- Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies
- (2008) Ignacio Melero et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search